Transient inhibition of murine progressive ankylosis by indomethacin
- 1 September 1991
- journal article
- research article
- Published by Springer Nature in Inflammation Research
- Vol. 34 (1-2) , 257-260
- https://doi.org/10.1007/bf01993297
Abstract
Murine progressive ankylosis (MPA) is an heritable disorder which produces acute arthritis and ankylosis of peripheral and axial joints similar to ankylosing spondylitis. Because indomethacin inhibits heterotopic bone formationin vivo, we studied its effects on MPA. Indomethacin was administered for 6 weeks beginning at weaning to litters from heterozygote breeder pairs. Progession curves for peripheral, spinal and thoracic joint ankylosis in treated and untreated ank/ank animals wer compared. There was no delay in ankylosis of peripheral or spinal joint ankylosis in MPA animals treated with indomethacin. interestingly, transient delay of thoracic ankylosis occurred in indomethacin treated MPA animals.Keywords
This publication has 9 references indexed in Scilit:
- PROGRESSIVE ANKYLOSIS (ANK ANK) IN MICE - AN ANIMAL-MODEL OF SPONDYLOARTHROPATHY .2. LIGHT AND ELECTRON-MICROSCOPIC FINDINGS1989
- Progressive ankylosis in miceArthritis & Rheumatism, 1988
- The use of indomethacin to prevent the formation of heterotopic bone after total hip replacement. A randomized, double-blind clinical trial.Journal of Bone and Joint Surgery, 1988
- Influence of indomethacin on induced heterotopic bone formation in rats. Importance of length of treatment and of age.1986
- Influence of indomethacin on experimental bone metabolism in rats.1985
- Influence of Indomethacin on Experimental Bone Metabolism in RatsPublished by Wolters Kluwer Health ,1985
- Progressive ankylosis, a new skeletal mutation in the mouseJournal of Heredity, 1981
- Ectopic ossification after total hip arthroplasty. Predisposing factors, frequency, and effect on resultsJournal of Bone and Joint Surgery, 1977